Immune checkpoint inhibition mediated with liposomal nanomedicine for cancer therapy.

Authors:
Ma GL; Lin WF.

Journal:
Mil Med Res

Publication Year: 2023

DOI:
10.1186/s40779-023-00455-x

PMCID:
PMC10142459

PMID:
37106400

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Mil Med Res

Abbreviation: Mil Med Res

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Military Medicine

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Acellular scaffold-based approach for in situ genetic engineering of host T-cells in solid tumor im…
Dandia HY; Pillai MM; Sharma D and 7 more (2024) - Transparency Score: 3/6
Antimicrobial resistance crisis: could artificial intelligence be the solution?
Liu GY; Yu D; Fan MM and 4 more (2024) - Transparency Score: 3/6
Biomaterial-based mechanical regulation facilitates scarless wound healing with functional skin app…
Li YY; Ji SF; Fu XB and 2 more (2024) - Transparency Score: 3/6
CT whole lung radiomic nomogram: a potential biomarker for lung function evaluation and identificat…
Zhou TH; Zhou XX; Ni J and 16 more (2024) - Transparency Score: 3/6
Disentangling the effects of PTSD from Gulf War Illness in male veterans via a systems-wide analysi…
Sultana E; Shastry N; Kasarla R and 8 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Ethics approval and consent to participateNot applicable. Consent for publicationNot applicable. Competing interestsThe authors declare that they have no competing interests. Competing interests The authors declare that they have no competing interests."

Evidence found in paper:

"Funding This work was supported by grants from the National Science Fund for Distinguished Young Scholars (Overseas)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025